Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clinical genitourinary cancer. 2023.11; ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer(タイトル和訳中) International Journal of Urology. 2023.07; 30 (7): 616-617. ( ichushi )

Soma Takahiko, Yoshida Soichiro, Wakejima Ryo, Taguchi Towako, Fukuda Shohei, Tanaka Hajime, Yokoyama Minato, Ohashi Kenichi, Okubo Kenichi, Fujii Yasuhisa. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy IJU Case Reports. 2023.07; 6 (4): 216-218. ( ichushi )

Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international. 2023.02; 131 (2): 219-226. ( PubMed, DOI )

Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; 30 (4): 381-388. ( PubMed, DOI )

Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022.12; 21 (4): e219-e227. ( PubMed, DOI )

Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I.. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis Front Oncol. 2022.11; ( DOI )

Yamaguchi Yoshitomo, Yokoyama Minato, Takemoto Akira, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. コハク酸脱水素酵素欠損性腎細胞癌を合併したコハク酸脱水素酵素欠損性の悪性パラガングリオーマ(Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma) IJU Case Reports. 2022.11; 5 (6): 480-483. ( ichushi )

Shimada Wataru, Kimura Koichiro, Tanaka Hajime, Fukuda Shohei, Yoshida Soichiro, Fujii Yasuhisa. 不規則な腫瘍形の重要性　cT1b-2N0M0腎細胞癌のpT3aへのステージ上昇を予測するためのダイナミックCTに基づくラジオミクス解析(Significance of tumor shape irregularity: Radiomics analysis based on dynamic computed tomography for predicting pT3a upstaging in cT1b-2N0M0 renal cell carcinoma) International Journal of Urology. 2022.11; 29 (11): 1387-1389. ( ichushi )

Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab Asia Pac J Clin Oncol (IF: 2.6; Q4). 2022.08;

Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08; 29 (8): 822-823.

Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y.. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clin Genitourin Cancer. . 2022.08;

Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia-Pacific journal of clinical oncology. 2022.08; 18 (4): 410-418. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. 「進行性腎細胞癌の一次治療としての複合癌免疫療法の包括的評価」に対するエディトリアルコメント(Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma) International Journal of Urology. 2022.08; 29 (8): 822-823. ( ichushi )

Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical genitourinary cancer. 2022.08; 20 (4): e276-e282. ( PubMed, DOI )

Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2022.08; 29 (8): 822-823. ( PubMed, DOI )

Tanaka H, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. Int J Urol. 2022.06; 29 (6): 501-502.

Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) (IF: 3.04; Q2). 2022.06;

Tanaka H, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. International journal of urology : official journal of the Japanese Urological Association. 2022.06; 29 (6): 501-502. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. 「転移性腎細胞癌に対する外科的局所治療　文献レビュー」に対するエディトリアルコメント(Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review) International Journal of Urology. 2022.06; 29 (6): 501-502. ( ichushi )

Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdominal radiology (New York). 2022.06; 47 (6): 2178-2186. ( PubMed, DOI )

Nityam Rathi, Diego A Palacios, Emily Abramczyk, Hajime Tanaka, Yunlin Ye, Jianbo Li, Yosuke Yasuda, Robert Abouassaly, Mohamed Eltemamy, Alvin Wee, Christopher Weight, Steven C Campbell. Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol. 2022.04; 40 (4): 1011-1018. ( PubMed, DOI )

Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol (IF: 3.5; Q3). 2022.04;

Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2022.04; 40 (4): 161.e15-161.e23. ( PubMed, DOI )

Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel) (IF: 5.25; Q2). 2022.03;

Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel, Switzerland). 2022.03; 12 (4): ( PubMed, DOI )

Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma BJU Int. 2022.02; 131 (2): 219-226.

Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol (IF: 5.32; Q1). 2022.02;

Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01;

Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology. 2022.01; 32 (1): 671-679. ( PubMed, DOI )

Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers. 2022.01; 14 (3): ( PubMed, DOI )

Preedanan W, Suzuki K, Kondo T, Kobayashi M, Tanaka H, Ishioka J, Matsuoka Y, Fujii Y, Kumazawa I. Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation. IEEE Access. 2022;

Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD . Kidney Cancer Screening and Epidemiology. Société Internationale d’Urologie Journal. 2022;

Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology. 2022; 12 995991. ( PubMed, DOI )

Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. 日本におけるロボット支援腎部分切除術の政府承認後2年間の動向と安全性　2016年から2018年までの全国データベース研究(Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018) International Journal of Urology. 2021.12; 28 (12): 1268-1272. ( ichushi )

Shimada Wataru, Tanaka Hajime, Fukawa Yuki, Kimura Koichiro, Yamamoto Kouhei, Fukuda Shohei, Fukushima Hiroshi, Yasuda Yosuke, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa. 局所進行腎細胞癌における浸潤性腫瘍の正常腎実質との界面　臨床的意義と病理学的意味(Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications) International Journal of Urology. 2021.12; 28 (12): 1233-1239. ( ichushi )

Shimada W, Tanaka H, Fukawa Y, Kimura K, Yamamoto K, Fukuda S, Fukushima H, Yasuda Y, Uehara S, Yoshida S, Yokoyama M, Matsuoka Y, Tateishi U, Campbell SC, Fujii Y. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. International journal of urology : official journal of the Japanese Urological Association. 2021.12; 28 (12): 1233-1239. ( PubMed, DOI )

Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel, Switzerland). 2021.12; 11 (12): ( PubMed, DOI )

Yokoyama M, Ishioka J, Toba M, Fukushima H, Tanaka H, Yoshida S, Matsuoka Y, Ai M, Fushimi K, Fujii Y. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. International journal of urology : official journal of the Japanese Urological Association. 2021.12; 28 (12): 1268-1272. ( PubMed, DOI )

Maruyama Riko, Fukushima Hiroshi, Fukuda Shohei, Yasuda Yosuke, Uehara Sho, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 副腎腫瘍および腎腫瘍の清潔手術における予防的抗菌薬の不使用　連続患者1362例を対象としたリスクベース戦略の結果(Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients) International Journal of Urology. 2021.10; 28 (10): 1032-1038. ( ichushi )

Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.10; 28 (10): 1032-1038. ( PubMed, DOI )

Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa. 外部放射線療法後の非転移性去勢抵抗性前立腺癌に対する救済小線源療法による治療(Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy) IJU Case Reports. 2021.07; 4 (4): 228-230. ( ichushi )

Sweet DE, Ward RD, Wang Y, Tanaka H, Campbell SC, Remer EM. Infiltrative Renal Malignancies: Imaging Features, Prognostic Implications, and Mimics. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021.03; 41 (2): 487-508. ( PubMed, DOI )

Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.03; 54 (2): 401-408. ( PubMed, DOI )

Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique INTERNATIONAL JOURNAL OF UROLOGY. 2021.03; 28 (3): 302-307. ( PubMed, DOI )

Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. 連続患者356例におけるガスレス単孔式腹腔鏡下腎部分切除術の治療成績　無阻血および無縫合手技の実施可能性(Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

Tanaka H, Fujii Y. Editorial Comment. The Journal of urology. 2021.02; 205 (5): 101097JU000000000000154902-1320. ( PubMed, DOI )

Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 16. ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Kijima Toshiki, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.01; 22 (2): ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 127-129. ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. systematic biopsyにより標的生検からアップグレードした前立腺癌の三次元解析　磁気共鳴-超音波画像融合システムを用いた標的辺縁部および周辺領域のサンプリングの可能性(Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

Soma Takahiko, Yokoyama Minato, Uchida Yusuke, Kirimura Susumu, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. 膀胱増大に起因する扁平上皮癌とリンパ節転移に対して根治的膀胱切除術と腸間膜リンパ節郭清を行い長期生存した症例　1症例報告(Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report) International Cancer Conference Journal. 2021.01; 10 (1): 20-23. ( ichushi )

Tanaka Hajime, Fujii Yasuhisa. 「膀胱癌に対するリンパ節郭清　現行の基準と最新のエビデンス」に対するエディトリアルコメント(Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence) International Journal of Urology. 2021.01; 28 (1): 16. ( ichushi )

Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. . Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol. 2020.12;

Tanaka Hajime. Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management(和訳中) International Journal of Urology. 2020.12; 27 (12): 1071. ( ichushi )

Tanaka Hajime. Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management INTERNATIONAL JOURNAL OF UROLOGY. 2020.12; 27 (12): 1071. ( PubMed, DOI )

Palacios Diego Aguilar, Campbell Rebecca, Wang Yanbo, Tanaka Hajime, Ding Xiaobo, Ye Yun-Lin, Remer Erick M., Rizk Alain, Ward Ryan, Haywood Samuel, Campbell Steven C.. Infiltrative Renal Masses: Clinical Challenges UROLOGY. 2020.11; 145 3-8. ( PubMed, DOI )

Fukushima Hiroshi, Kijima Toshiki, Fukuda Shohei, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Matsubara Nobuaki, Numao Noboru, Sakai Yasuyuki, Yuasa Takeshi, Masuda Hitoshi, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study CANCER MEDICINE. 2020.11; 9 (22): 8355-8363. ( PubMed, DOI )

田中 一, 木島 敏樹, 福田 翔平, 福島 啓司, 安田 庸輔, 森山 真吾, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久. 局所限局性浸潤性膀胱癌の実践治療　筋層浸潤膀胱癌に対する4者併用膀胱温存療法 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS13-1. ( ichushi )

福島 啓司, 木島 敏樹, 安田 庸輔, 森山 真吾, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 松原 伸晃, 湯浅 健, 増田 均, 米瀬 淳二, 影山 幸雄, 藤井 靖久. 進行・転移性膀胱癌治療のup-to-date　進行尿路上皮癌に対するペムブロリズマブ治療における化学放射線療法の意義 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS14-1. ( ichushi )

Fukushima Hiroshi, Fukuda Shohei, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report ANTI-CANCER DRUGS. 2020.09; 31 (8): 866-871. ( PubMed, DOI )

Tanaka Hajime. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision(和訳中) International Journal of Urology. 2020.09; 27 (9): 710. ( ichushi )

Tanaka Hajime. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 710. ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 760-766. ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( ichushi )

Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

Nakamura Yuki, Yokoyama Minato, Yoshida Soichiro, Tanaka Hajime, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Minami Isao, Yoshimoto Takanobu, Naito Shotaro, Ogawa Yoshihiro, Yamada Tetsuya, Uchida Shinichi, Fujii Yasuhisa. クッシング症候群患者における副腎摘除後の術後腎機能障害と長期にわたる腎機能変化(Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome) International Journal of Urology. 2020.05; 27 (5): 395-400. ( ichushi )

Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 236-243. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 257. ( PubMed, DOI )

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

Tanaka Hajime, Fujii Yasuhisa. 「膀胱癌に対する根治的腹腔鏡下膀胱全摘術後の腫瘍学的成績と再発パターン　日本の多施設コホート」に対するDr.TanakaとDr.Fujiiによるエディトリアルコメント(Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort) International Journal of Urology. 2020.03; 27 (3): 257. ( ichushi )

Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( ichushi )

Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, Lin L, Li J, Abouassaly R, Campbell SC. Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy. The Journal of urology. 2020.02; 101097JU0000000000000797. ( PubMed, DOI )

Ye Yunlin, Tanaka Hajime, Wang Yanbo, Campbell Rebecca A., Aguilar Palacios Diego, DeWitt-Foy Molly E., Mahmood Furman A., Eltemamy Mohamed, Remer Erick M., Li Jianbo, Campbell Steven C.. Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans BJU INTERNATIONAL. 2020.02; 125 (5): 686-694. ( PubMed, DOI )

Tanaka H, Kijima T, Fujii Y. Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives AME Medical Journal. 2020.02;

Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; 7 (2): 366-372. ( PubMed, DOI )

Ye Y*, Tanaka H*, Wang Y, Campbell RA, Aguilar Palacios D, Dewitt-Foy ME, Mahmood FA, Eltemamy M, Remer EM, Li J, Campbell SC. Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans BJU International. 2020; 125: 686-694. *Equal contribution. 2020;

Tanaka H. Editorial Comment to Retroperitoneal tumors: review of diagnosis and management Int J Urol. 2020; 27: 1071. 2020;

Tanaka H. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association -Summary of the Revision Int J Urol. 2020. doi: 10.1111/iju.14314. 2020;

Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

Tanaka H, Fujii Y. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

Tanaka H, Fujii Y. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

ToshikiKijimaHajimeTanakaShoUeharaSoichiroYoshidaMinatoYokoyamaJunichiroIshiokaYohMatsuokaKazutakaSaitoKazunoriKiharaYasuhisaFujii. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer. 2019.11; ( PubMed, DOI )

Rebecca A Campbell, Molly E DeWitt-Foy, Hajime Tanaka, Yun-Lin Ye, Yanbo Wang, Jeffrey Reese, Venkatesh Krishnamurthi, Wen Dong, Steven C Campbell. Functional Recovery From Prolonged Warm Ischemia: Compelling Case Scenarios. Urology. 2019.10; 132 22-27. ( PubMed, DOI )

Toshiki Kijima, Hajime Tanaka, Fumitaka Koga, Hitoshi Masuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int.. 2019.08; 124 (2): 242-250. ( PubMed, DOI )

Masaki Kobayashi, Hajime Tanaka, Ukihide Tateishi, Noboru Numao, Junji Yonese, Masaya Ito, Fumitaka Koga, Hiroshi Fukushima, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int. J. Urol.. 2019.08; 26 (8): 820-826. ( PubMed, DOI )

Yanbo Wang, Hajime Tanaka, Yunlin Ye, Xiaobo Ding, Ryan D Ward, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Erick M Remer, Steven C Campbell. The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications. Urology. 2019.08; 130 86-92. ( PubMed, DOI )

Hajime Tanaka, Xiaobo Ding, Yunlin Ye, Yanbo Wang, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Ryan D Ward, Erick M Remer, Jianbo Li, Steven C Campbell. Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019.08; ( PubMed, DOI )

Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 転移性尿路上皮癌患者の化学療法感受性と生存率にPET/CTでのフルオロデオキシグルコース取り込みが及ぼす影響(Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma) International Journal of Urology. 2019.08; 26 (8): 820-826. ( ichushi )

Chalairat Suk-Ouichai, Hajime Tanaka, Yanbo Wang, Jitao Wu, Yunlin Ye, Sevag Demirjian, Jianbo Li, Steven C Campbell. Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy? J. Urol.. 2019.06; 201 (6): 1088-1096. ( PubMed, DOI )

Hajime Tanaka, Yanbo Wang, Chalairat Suk-Ouichai, Diego Aguilar Palacios, Elvis R Caraballo, Yunlin Ye, Erick M Remer, Jianbo Li, Robert Abouassaly, Steven C Campbell. Can We Predict Functional Outcomes after Partial Nephrectomy? J. Urol.. 2019.04; 201 (4): 693-701. ( PubMed, DOI )

Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.04; 44 (4): 1230-1236. ( PubMed, DOI )

Elvis R Caraballo, Diego Aguilar Palacios, Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, Brian R Lane, Steven C Campbell. Open partial nephrectomy when a non-flank approach is required: indications and outcomes. World J Urol. 2019.03; 37 (3): 515-522. ( PubMed, DOI )

Jitao Wu, Chalairat Suk-Ouichai, Wen Dong, Zhiling Zhang, Hajime Tanaka, Yanbo Wang, Elvis Caraballo, Erick M Remer, Jianbo Li, Sudhir Isharwal, Robert Abouassaly, Steven C Campbell. Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors. Eur Urol Oncol. 2019.02; 2 (1): 97-103. ( PubMed, DOI )

Naoko Kawamura, Minato Yokoyama, Hajime Tanaka, Takayuki Nakayama, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. Int. J. Urol.. 2019.01; 26 (1): 113-118. ( PubMed, DOI )

Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( ichushi )

Soma Takahiko, Ishioka Junichiro, Tanaka Hajime, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 造影CTとT2強調MRIによる脂肪に乏しい血管筋脂肪腫の診断を目的とした畳み込みニューラルネットワークアルゴリズムを用いたコンピュータ補助診断の可能性(Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging) International Journal of Urology. 2018.11; 25 (11): 978-979. ( ichushi )

Ryan D Ward, Hajime Tanaka, Steven C Campbell, Erick M Remer. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Radiographics. 2018.11; 38 (7): 2021-2033. ( PubMed, DOI )

Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; ( PubMed, DOI )

Alice Crane, Chalairat Suk-Ouichai, Jack A Campbell, Elvis R Caraballo, Diego Aguilar Palacios, Hajime Tanaka, Steven C Campbell. Imprudent Utilization of Partial Nephrectomy. Urology. 2018.07; 117 22-26. ( PubMed, DOI )

Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed, DOI )

Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, J J H Zhang, Elvis Caraballo, Erick Remer, Jianbo Li, Sudhir Isharwal, Steven C Campbell. Tumor Contact Surface Area As a Predictor of Functional Outcomes After Standard Partial Nephrectomy: Utility and Limitations. Urology. 2018.06; 116 106-113. ( PubMed, DOI )

Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. T2強調MRIにおける小径腎腫瘍の信号強度比曲線解析　脂肪成分の少ない腎血管筋脂肪腫と腎細胞癌との鑑別(Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. pT1膀胱癌の進行に関する拡散強調MRI上のinchworm sign欠如の予測的意義(Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer) 日本泌尿器科学会総会. 2018.04; 106回 IS-75. ( ichushi )

Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. ガスレス単孔式腹腔鏡下clampless無縫合腎部分切除術　周術期転帰(Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes) 日本泌尿器科学会総会. 2018.04; 106回 IS-68. ( ichushi )

Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.03; ( PubMed, DOI )

Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed, DOI )

Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara. Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa, Tanaka Hiroshi, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Uehara Sho, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Kihara Kazunori. 小径腎腫瘍中の脂肪成分の少ない腎血管筋脂肪腫診断のためのCTおよびMRIを用いたステップワイズアルゴリズム　開発および外的妥当性(Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation) International Journal of Urology. 2017.07; 24 (7): 511-517. ( ichushi )

Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara. Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. 無阻血・無縫合法による低侵襲性腎部分切除術後のCTにおける仮性腎動脈瘤の非描出(Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques) International Journal of Urology. 2017.06; 24 (6): 472-473. ( ichushi )

Tanaka Hajime, Yoshida Soichiro, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 免疫組織化学に基づいた分子的サブタイプ判定による筋層浸潤性膀胱癌における化学放射線療法に対する感受性の予測(Immunohistochemistry-based molecular subtypes predict therapeutic sensitivity of chemoradiotherapy in muscle-invasive bladder cancer) 日本泌尿器科学会総会. 2017.04; 105回 AOP11-07. ( ichushi )

Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol. Int.. 2016.01; 96 (1): 65-72. ( PubMed, DOI )

Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Mizuaki Sakura, Hajime Tanaka, Tatsuro Hayashi, Sho Uehara, Yasushi Inoue, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Junji Yonese. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1171-1178. ( PubMed, DOI )

Takeshi Yuasa, Naoko Inoshita, Hajime Tanaka, Shinji Urakami, Shinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Yuichi Ishikawa, Junji Yonese. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1198-1202. ( PubMed, DOI )

Hajime Tanaka, Takeshi Yuasa, Yasuhisa Fujii, Mizuaki Sakura, Shinji Urakami, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. Chemotherapy. 2013; 59 (6): 441-446. ( PubMed, DOI )

Yuma Waseda, Hajime Tanaka, Kazuaki Nakagomi, Shuichi Goto, Akio Ido. A case of hereditary persistence of α-fetoprotein: diagnostic usefulness of the subfraction profile. Jpn. J. Clin. Oncol.. 2012.08; 42 (8): 767-769. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2012.05; 83 (1): e21-e27. ( PubMed, DOI )

Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011.10; 18 (10): 727-730. ( PubMed, DOI )

Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa, Yoshimura Ryoichi, Tateishi Ukihide. 筋層浸潤膀胱癌に対する膀胱温存療法の治療効果予測におけるVI-RADSの臨床的意義(Clinical Significance of the Vesical Imaging Reporting and Data System in Predicting the Therapeutic Effect of Bladder-Sparing Treatment in Muscle-Invasive Bladder Cancer). 日本医学放射線学会学術集会抄録集 2022.03.01

Tanaka Hajime. Prognostic impact of pathological renal parenchymal infiltration in non-metastatic clear cell renal cell carcinoma. AUA Annual Meeting 2022

Tanaka Hajime. Renal parenchymal infiltration is the primary determinant of prognosis of patients with non-metastatic clear cell renal cell carcinoma. 37th Annual EAU Congress 2022

Tanaka Hajime. Disparities in Cancer-Specific Mortality between Asian and Caucasian Patients with Non-metastatic Renal Cell Carcinoma: Analysis of the INMARC registry. 37th Annual EAU Congress 2022

上原 翔, 松岡 陽, 山本 くらら, 戸出 真宏, 内田 裕將, 福田 翔平, 福島 啓司, 安田 庸輔, 田中 一, 吉田 宗一郎, 横山 みなと, 大橋 健一, 藤井 靖久. 前立腺の篩状癌と腺管内癌の検出におけるMRI標的生検の有用性(Usefulness of MRI-targeted biopsy in detecting cribriform carcinoma and intraductal carcinoma of the prostate). 日本泌尿器科学会総会 2021.12.01

山口 良友, 田中 一, 福島 啓司, 戸出 真宏, 内田 裕將, 福田 翔平, 安田 庸輔, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久. 原発性腎腫瘍の放射線学的浸潤性特徴が転移性腎細胞癌の予後へ及ぼす影響(Prognostic impact of radiologic infiltrative feature of primary renal tumor in metastatic renal cell carcinoma). 日本泌尿器科学会総会 2021.12.01

田中 一, 島田 航, 布川 裕規, 木村 浩一朗, 山本 浩平, 福田 翔平, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 立石 宇貴秀, 藤井 靖久. 局所進行腎細胞癌における正常腎実質浸潤の意義　画像および組織学的所見に基づく考察. 日本癌治療学会学術集会抄録集 2021.10.01

田中　一. Significance of Radiologic Infiltrative Feature of Primary Renal Tumor in Predicting Patient Survival in Metastatic Renal Cell Carcinoma. AUA Annual Meeting 2021.09.10 web

Tanaka Hajime. Prognostic significance of radiologic infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. 36th Annual EAU Congress 2021.07.10 web

福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後：化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

Uehara Sho, Matsuoka Yoh, Tanaka Hiroshi, Fukuda Shohei, Fukushima Hiroshi, Moriyama Shingo, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. 標的外のsystematic biopsy coreは前立腺がんの有意な検出に対して限定的な意義しかない　MRI多平面再構築を用いた分析(Systematic biopsy cores apart from targets are of limited value for significant prostate cancer detection: Analysis using MRI multiplanar reconstruction). 日本泌尿器科学会総会 2020.12.01

Kijima Toshiki, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Masuda Hitoshi, Matsubara Nobuaki, Yuasa Takeshi, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. 進行性尿路上皮がん患者における免疫関連有害事象とpembrolizumabの有効性の関連性(Association between immune-related adverse events and efficacy of pembrolizumab in advanced urothelial cancer patients). 日本泌尿器科学会総会 2020.12.01

Tanaka Hajime, Shimada Wataru, Fukuda Shohei, Fukushima Hiroshi, Uehara Sho, Moriyama Shingo, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 臨床的に限局性の腎細胞癌の腫瘍学的転帰の予測における腫瘍不定形性形状の意義(Significance of tumor shape irregularity in predicting oncologic outcomes of clinically localized renal cell carcinoma). 日本泌尿器科学会総会 2020.12.01

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise diagnostic algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility of non-use of antimicrobial prophylaxis in clean urologic surgeries for adrenal and renal tumors: A prospective single-institutional study of 1339 patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam Netherlands

Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

1 Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.17 Denmark

Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical　recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害：発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析：筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu,　Ito　Masaya,　Kijima　Toshiki,　Yoshida　Soichiro,　Yokoyama　Minato,　Ishioka　Junichiro,　Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction　. 32nd Annual EAU Congress 2017.03.27 London、England

13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.08 USA

Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07

Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego

Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Germany

Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Munich, Germany

Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13

Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Tatsuro Hayashi, Mizuaki Sakura, Shinji Urakami, Tokyo, Japan, Yasuyuki Sakai, Chiba, Japan, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. The value of 18 F-FDG PET/CT in staging of upper tract urothelial carcinoma: impact on patient management. . AUA Annual Meeting 2014 2014.05.16